Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/201284
Type: Artigo de periódico
Title: S-nitrosoglutathione Inhibits Inducible Nitric Oxide Synthase Upregulation By Redox Posttranslational Modification In Experimental Diabetic Retinopathy.
Author: Rosales, Mariana A B
Silva, Kamila C
Duarte, Diego A
de Oliveira, Marcelo G
de Souza, Gabriela F P
Catharino, Rodrigo R
Ferreira, Mônica S
Lopes de Faria, Jose B
Lopes de Faria, Jacqueline M
Abstract: Diabetic retinopathy (DR) is associated with nitrosative stress. The purpose of this study was to evaluate the beneficial effects of S-nitrosoglutathione (GSNO) eye drop treatment on an experimental model of DR. Diabetes (DM) was induced in spontaneously hypertensive rats (SHR). Treated animals received GSNO eye drop (900 nM or 10 μM) twice daily in both eyes for 20 days. The mechanisms of GSNO effects were evaluated in human RPE cell line (ARPE-19). In animals with DM, GSNO decreased inducible nitric oxide synthase (iNOS) expression and prevented tyrosine nitration formation, ameliorating glial dysfunction measured with glial fibrillary acidic protein, resulting in improved retinal function. In contrast, in nondiabetic animals, GSNO induced oxidative/nitrosative stress in tissue resulting in impaired retinal function. Nitrosative stress was present markedly in the RPE layer accompanied by c-wave dysfunction. In vitro study showed that treatment with GSNO under high glucose condition counteracted nitrosative stress due to iNOS downregulation by S-glutathionylation, and not by prevention of decreased GSNO and reduced glutathione levels. This posttranslational modification probably was promoted by the release of oxidized glutathione through GSNO denitrosylation via GSNO-R. In contrast, in the normal glucose condition, GSNO treatment promoted nitrosative stress by NO formation. In this study, a new therapeutic modality (GSNO eye drop) targeting nitrosative stress by redox posttranslational modification of iNOS was efficient against early damage in the retina due to experimental DR. The present work showed the potential clinical implications of balancing the S-nitrosoglutathione/glutathione system in treating DR.
Subject: Analysis Of Variance
Animals
Biological Markers
Cell Line
Diabetes Mellitus, Experimental
Diabetic Retinopathy
Disease Models, Animal
Electroretinography
Glial Fibrillary Acidic Protein
Glutathione
Humans
Nitric Oxide Donors
Nitric Oxide Synthase Type Ii
Ophthalmic Solutions
Rats
Reactive Oxygen Species
Retina
S-nitrosoglutathione
Tyrosine
Up-regulation
S-glutathionylation
S-nitrosoglutathione
Diabetic Retinopathy
Nitrosative Stress
Retinal Pigment Epithelium
Rights: fechado
Identifier DOI: 10.1167/iovs.13-13762
Address: http://www.ncbi.nlm.nih.gov/pubmed/24699383
Date Issue: 2014
Appears in Collections:Artigos e Materiais de Revistas Científicas - Unicamp

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.